Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases
- PMID: 28544079
- DOI: 10.1111/resp.13084
Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases
Abstract
Background and objective: The objectives of this study were to determine the prevalence and characteristics of cough in idiopathic pulmonary fibrosis (IPF), chronic hypersensitivity pneumonitis (HP) and systemic sclerosis-associated interstitial lung disease (SSc-ILD).
Methods: Cough severity was measured in consecutive patients with IPF (n = 77), HP (n = 32) and SSc-ILD (n = 67) using a 10-cm visual analogue scale (VAS). Dyspnoea and quality of life were measured using established questionnaires. Cough severity was compared across ILD subtypes and predictors of cough severity were determined using multivariate analysis.
Results: Cough was more common in IPF and chronic HP compared to SSc-ILD (87% and 83% vs 68%, P = 0.02). The median (interquartile range) VAS score was 39 (17-65) in the IPF cohort, 29 (11-48) in HP and 18 (0-33) in SSc-ILD (P < 0.0001). Cough was more often productive in chronic HP and IPF (63% and 43% vs 21%, P < 0.001). Cough severity was independently predicted only by ILD diagnosis and higher dyspnoea score. Cough severity was not associated with other common causes of cough. Cough was a significant predictor of quality of life in IPF and SSc-ILD with adjustment for age, sex, dyspnoea and ILD severity; however, cough was not associated with quality of life in chronic HP.
Conclusion: Cough is more frequent, more severe and more often productive in IPF and chronic HP compared to SSc-ILD, despite similar ILD severity in these cohorts. Cough severity is strongly and independently associated with dyspnoea and pulmonary function, and is a significant contributor to reduced quality of life in both IPF and SSc-ILD.
Keywords: cough; dyspnoea; hypersensitivity pneumonitis; idiopathic pulmonary fibrosis; systemic sclerosis.
© 2017 Asian Pacific Society of Respirology.
Comment in
-
Cough in fibrotic lung disease: An unresolved challenge.Respirology. 2017 Nov;22(8):1491-1492. doi: 10.1111/resp.13116. Epub 2017 Jul 4. Respirology. 2017. PMID: 28677213 No abstract available.
Similar articles
-
Severity and features of frailty in systemic sclerosis-associated interstitial lung disease.Respir Med. 2017 Aug;129:1-7. doi: 10.1016/j.rmed.2017.05.012. Epub 2017 May 25. Respir Med. 2017. PMID: 28732817
-
Epidemiology and Prognostic Significance of Cough in Fibrotic Interstitial Lung Disease.Am J Respir Crit Care Med. 2024 Oct 15;210(8):1035-1044. doi: 10.1164/rccm.202311-2101OC. Am J Respir Crit Care Med. 2024. PMID: 38536110
-
ILD-specific health-related quality of life in systemic sclerosis-associated ILD compared with IPF.BMJ Open Respir Res. 2020 Jun;7(1):e000598. doi: 10.1136/bmjresp-2020-000598. BMJ Open Respir Res. 2020. PMID: 32576559 Free PMC article.
-
The burden of cough in idiopathic pulmonary fibrosis and other interstitial lung diseases: a systematic evidence synthesis.Respir Res. 2024 Aug 27;25(1):325. doi: 10.1186/s12931-024-02897-w. Respir Res. 2024. PMID: 39192278 Free PMC article.
-
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020. Front Immunol. 2020. PMID: 33013852 Free PMC article. Review.
Cited by
-
Hypersensitivity pneumonitis.Nat Rev Dis Primers. 2020 Aug 6;6(1):65. doi: 10.1038/s41572-020-0191-z. Nat Rev Dis Primers. 2020. PMID: 32764620 Review.
-
Cough in Idiopathic Pulmonary Fibrosis.Front Rehabil Sci. 2021 Oct 18;2:751798. doi: 10.3389/fresc.2021.751798. eCollection 2021. Front Rehabil Sci. 2021. PMID: 36188759 Free PMC article. Review.
-
Treatable Traits in Systemic Sclerosis.Clin Rev Allergy Immunol. 2023 Oct;65(2):251-276. doi: 10.1007/s12016-023-08969-x. Epub 2023 Aug 21. Clin Rev Allergy Immunol. 2023. PMID: 37603199 Review.
-
Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.Clin Rheumatol. 2023 Mar;42(3):653-661. doi: 10.1007/s10067-022-06408-4. Epub 2022 Oct 21. Clin Rheumatol. 2023. PMID: 36271064 Free PMC article. Review.
-
Determinants of cough-related quality of life in interstitial lung diseases.BMC Pulm Med. 2024 Aug 29;24(1):427. doi: 10.1186/s12890-024-03218-z. BMC Pulm Med. 2024. PMID: 39210302 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous